Association of Cannabinoid Specialists
Jordan Tishler MD is an accomplished physician and medical educator with extensive experience in cannabinoid medicine. Serving as the President of the Association of Cannabinoid Specialists since February 2018, Jordan Tishler emphasizes patient care and best practices in cannabis therapeutics. In addition to this role, Jordan Tishler is an Instructor of Medicine at Harvard Medical School and holds the positions of Chief Executive Officer and Chief Medical Officer at inhaleMD, focusing on effective treatment plans for patients utilizing cannabis. With a background as a physician at Brigham and Women's Hospital and prior experience in emergency and urgent care settings, Jordan Tishler has also contributed to academia as an Adjunct Professor of Management at Northeastern University and through teaching roles at Harvard Medical School. Jordan Tishler holds a Doctor of Medicine degree from Harvard Medical School and has a foundational education in Neurobiology and Behavior from Harvard University.
This person is not in any teams
Association of Cannabinoid Specialists
The Association of Cannabis Specialists ensures the highest standards in the practice of cannabis medicine, safeguards patient care with clinical best practices, and interfaces with other stakeholders in the cannabis community. We believe that patients are uniquely vulnerable and have very different needs than recreational users. We provide evidence and experience-based education for patients, cannabis clinicians, referring clinicians, and lawmakers to help them understand cannabis medicine and make informed decisions. We are a political organization striving to implement best practices in the laws and regulations at the federal, state, and international levels. Our Core Values: • Patients are a vulnerable group who deserve the highest standard of medical care and products. • Recreational use is not the same as medical use. These groups have different goals and needs and must be addressed separately. • Prohibition of cannabis is a major public health hazard that has failed to decrease drug use and has led to unsupportable consequences. • Cannabis is medicine. It should be regulated like other medications and be available by prescription including in botanical form. • Cannabis products should not make unsubstantiated medical claims. Products should be required to meet strict standards of safety, bioavailability, and efficacy. • Dispensaries should operate like pharmacies. They should provide products that are safe and effective. They should not provide medical advice to patients. They should not contradict patients’ clinicians’ orders.